In order to treat effectively and repair the disease of drug addiction, the critical mediators and defects in the brain must be known. While some mediators and defects or changes due to drugs are known, all the critical ones may not be fully known or understood. This proposal deals with a relatively new neurochemical that appears to play a role in the action of psychostimulant drugs such as cocaine and methamphetamine. This neurochemical is actually a small group of peptides referred to as CART peptides. They were discovered by giving animals cocaine or amphetamine, and CART peptides are found in many brain regions involved in reward and reinforcement. Moreover, some CART peptides, upon injection into the brain, produce effects that are psychostimulant-like suggesting that they may mediate, at least partly, some of the actions of these drugs. This proposal further characterizes the behavioral effects of CART peptides and explores the neurochemical and neuroanatomical bases for these effects. All known active CART peptides will be injected into brain regions associated with reward and reinforcement and it will be noted if they produce effects similar to those produced by psychostimulants. The interaction of CART peptides with cocaine and dopamine will be carefully analyzed. The precise location of endogenously occurring CART peptides will be delineated by light and electron microscopy in drug dependence-related neurocircuits. Taken together, these findings will substantially increase our knowledge of the role of CART peptides in the action of psychostimulant drugs, may enhance our understanding of the process of drug dependence, and may suggest targets for development of medications for psychostimulant abusers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA010732-08
Application #
6891865
Study Section
Integrative, Functional and Cognitive Neuroscience 8 (IFCN)
Program Officer
Colvis, Christine
Project Start
1998-01-15
Project End
2007-04-30
Budget Start
2005-05-01
Budget End
2007-04-30
Support Year
8
Fiscal Year
2005
Total Cost
$360,000
Indirect Cost
Name
Emory University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Brennan, D J; O'Connor, D P; Laursen, H et al. (2012) The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER?, and is an independent prognostic factor in node-negative breast cancer. Oncogene 31:3483-94
Balkan, Burcu; Gozen, Oguz; Koylu, Ersin O et al. (2012) Region- and sex-specific changes in CART mRNA in rat hypothalamic nuclei induced by forced swim stress. Brain Res 1479:62-71
Kuhar, Michael J (2011) Collegial ethics: what, why and how. Drug Alcohol Depend 119:235-8
Keating, Glenda L; Kuhar, Michael J; Bliwise, Donald L et al. (2010) Wake promoting effects of cocaine and amphetamine-regulated transcript (CART). Neuropeptides 44:241-6
Jones, D C; Lakatos, A; Rogge, G A et al. (2009) Regulation of cocaine- and amphetamine-regulated transcript mRNA expression by calcium-mediated signaling in GH3 cells. Neuroscience 160:339-47
Keating, Glenda L; Kuhar, Michael J; Rye, David B (2008) High dose CART peptide induces abnormal EEG activity and behavioral seizures. Neuropeptides 42:199-204
Hubert, George W; Jones, Douglas C; Moffett, Mark C et al. (2008) CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol 75:57-62
Jones, Douglas C; Kuhar, Michael J (2008) CART receptor binding in primary cell cultures of the rat nucleus accumbens. Synapse 62:122-7
Jaworski, Jason N; Hansen, Stephen T; Kuhar, Michael J et al. (2008) Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav Brain Res 191:266-71
Hubert, G W; Kuhar, M J (2008) Cocaine administration increases the fraction of CART cells in the rat nucleus accumbens that co-immunostain for c-Fos. Neuropeptides 42:339-43

Showing the most recent 10 out of 70 publications